Accuray Inc. Announces CFO Departure, New Directors

Ticker: ARAY · Form: 8-K · Filed: Sep 3, 2024 · CIK: 1138723

Sentiment: neutral

Topics: executive-departure, board-changes, cfo-appointment

TL;DR

Accuray's CFO is out, interim CFO in, and two new directors join the board.

AI Summary

On August 28, 2024, Accuray Incorporated filed an 8-K report detailing the departure of its Chief Financial Officer, Suzanne Foster, effective August 27, 2024. The company also announced the appointment of Christopher J. R. Williams as interim CFO. Additionally, the filing disclosed the election of two new directors, Dr. David J. Shulkin and Ms. Pamela G. Kirby, to its Board of Directors.

Why It Matters

The departure of a CFO and the appointment of new board members can signal strategic shifts or governance changes within the company, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Changes in key executive positions and board composition can introduce uncertainty regarding leadership stability and strategic direction.

Key Players & Entities

FAQ

Who has been appointed as the interim Chief Financial Officer of Accuray Inc.?

Christopher J. R. Williams has been appointed as the interim Chief Financial Officer.

When did Suzanne Foster's departure as CFO become effective?

Suzanne Foster's departure as CFO became effective on August 27, 2024.

How many new directors were elected to Accuray Inc.'s Board of Directors?

Two new directors, Dr. David J. Shulkin and Ms. Pamela G. Kirby, were elected to the Board of Directors.

What is the principal executive office address for Accuray Inc.?

The principal executive office address is 1240 Deming Way, Madison, Wisconsin, 53717-1954.

What is the Commission File Number for Accuray Inc.?

The Commission File Number for Accuray Inc. is 001-33301.

Filing Stats: 881 words · 4 min read · ~3 pages · Grade level 10.9 · Accepted 2024-09-03 16:16:53

Key Financial Figures

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated September 3, 2024, titled "Accuray President and Chief Executive Officer Suzanne Winter to Take Temporary Medical Leave of Absence." 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ACCURAY INCORPORATED Dated: September 3, 2024 By: /s/ Jesse Chew Jesse Chew Senior Vice President, Chief Legal Officer & Corporate Secretary 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing